Resistencia a fármacos antituberculosos en Cuba, 2015-2017 / Resistance to tuberculosis drugs in Cuba, 2015-2017
Rev. cuba. med. trop
;
73(1): e590, tab
Article
in Spanish
| LILACS, CUMED
| ID: biblio-1280329
RESUMEN
Introducción:
La tuberculosis persiste como un importante problema de salud mundial. En el 2016 se estimaron 600 000 casos de resistente a rifampicina, y entre estos 490 000 casos multidrogorresistentes.Objetivo:
Describir el comportamiento de la resistencia de los aislados de M. tuberculosis de pacientes con tuberculosis pulmonar notificados en Cuba entre los años 2015-2017.Métodos:
Se determinó la susceptibilidad a isoniacida y rifampicina mediante el método de la nitratasa. A los aislados resistentes a rifampicina/multidrogorresistentes se les determinó mediante el método proporcional la susceptibilidad a ofloxacina, kanamicina, amikacina y capreomicina.Resultados:
El 93,2 por ciento de los aislados fueron sensibles a isoniacida y rifampicina. En 39 se identificó resistencia a isoniacida y 23 fueron resistente a rifampicina. Se identificaron 10 multidrogorresistentes. No se detectó resistencia a fármacos de segunda línea.Conclusiones:
Los resultados alertan sobre la necesidad de investigar las causas que han conllevado al incremento de la tuberculosis resistente en Cuba(AU)ABSTRACT
Introduction:
Tuberculosis continues to be an important health problem worldwide. In the year 2016, as many as 600 000 cases of rifampicin resistance were estimated, among which 490 000 were multi-drug resistant.Objective:
Describe the behavior of resistance to M. tuberculosis isolates in patients with pulmonary tuberculosis reported in Cuba in the period 2015-2017.Methods:
Susceptibility to isoniazid and rifampicin was determined by the nitratase method. Susceptibility of rifampicin resistant / multi-drug resistant isolates to ofloxacin, kanamycin, amikacin and capreomycin was determined by the proportional method.Results:
Of the isolates analyzed, 93.2 percent were sensitive to isoniazid and rifampicin. Isoniazid resistance was identified in 39 and 23 were rifampicin resistant. Ten multi-drug resistant isolates were identified. Resistance to second line drugs was not detected.Conclusions:
Results warn about the need to study the factors leading to the increase in resistant tuberculosis in Cuba(AU)
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Tuberculosis, Multidrug-Resistant
/
Drug Resistance, Multiple, Bacterial
Type of study:
Prognostic study
Limits:
Humans
Country/Region as subject:
Cuba
Language:
Spanish
Journal:
Rev. cuba. med. trop
Journal subject:
Tropical Medicine
Year:
2021
Type:
Article
Affiliation country:
Cuba
Institution/Affiliation country:
Instituto de Medicina Tropical Pedro Kourí/CU
/
Ministerio de Salud Pública/CU
/
Universidad de la Habana/CU
Similar
MEDLINE
...
LILACS
LIS